Mouse Model of Multiple System Atrophy α-Synuclein Expression in Oligodendrocytes Causes Glial and Neuronal Degeneration

Yazawa, Ikuru, Giasson, Benoit I., Sasaki, Ryogen, Zhang, Bin, Joyce, Sonali, Uryu, Kunihiro, Trojanowski, John Q., Lee, Virginia M.-Y.·2005·Neuron

Cited by (301)

Items 101–200 of 301

  1. Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases
    Carmen I. Nussbaum-Krammer, Richard I. Morimoto · 2014 · Disease Models & Mechanisms
  2. Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals
    Toshiro Kanazawa, Eijiro Adachi, Satoshi Orimo, Ayako Nakamura, Hidehiro Mizusawa, Toshiki Uchihara · 2011 · Brain Pathology
  3. Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
    Aniket Ghosh, Natalia Manrique‐Hoyos, Aaron Voigt, Jörg Bernhard Schulz, Mario Kreutzfeldt, Doron Merkler, Mikael Simons · 2011 · PLoS ONE
  4. The Oligomer Hypothesis in α-Synucleinopathy
    Kenjiro Ono · 2017 · Neurochemical Research
  5. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases
    Seung-Wan Han, Yunho Gim, Eun‐Hae Jang, Eun‐Mi Hur · 2022 · Frontiers in Cellular Neuroscience
  6. Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells
    Ettle, Benjamin, Reiprich, Simone, Deusser, Janina, Schlachetzki, Johannes C.M., Xiang, Wei, Prots, Iryna, Masliah, Eliezer, Winner, Beate, Wegner, Michael, Winkler, Jürgen · 2014 · Molecular and Cellular Neuroscience
  7. A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
    Guadalupe Vidal-Martínez, Brandon Chin, Cynthia Camarillo, Gloria V. Herrera, Barbara Carolyn Yang, Irene Sarosiek, Ruth G. Perez · 2019 · Journal of Parkinson s Disease
  8. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates
    Mandel, Ronald J., Marmion, David J., Kirik, Deniz, Chu, Yaping, Heindel, Clifford, McCown, Thomas, Gray, Steven J., Kordower, Jeffrey H. · 2017 · Acta Neuropathologica Communications
  9. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
    Mie Hirohata, Kenjiro Ono, Akiyoshi Morinaga, Masahito Yamada · 2007 · Neuropharmacology
  10. Review: Multiple system atrophy: emerging targets for interventional therapies
    Nadia Stefanova, Gregor Karl Wenning · 2016 · Neuropathology and Applied Neurobiology
  11. Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice
    Emily J. Koller, Mieu Brooks, Todd Eliot Golde, Benoit I. Giasson, Paramita Chakrabarty · 2017 · Molecular Neurodegeneration
  12. α-Synuclein aggregation in the olfactory bulb induces olfactory deficits by perturbing granule cells and granular–mitral synaptic transmission
    Fengjiao Chen, Wei Liu, Penglai Liu, Zhen Wang, You Zhou, Xingyu Liu, Anan Li · 2021 · npj Parkinson s Disease
  13. The Membrane Interactions of Synuclein: Physiology and Pathology
    Gautam Runwal, Robert H. Edwards · 2021 · Annual Review of Pathology Mechanisms of Disease
  14. Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases
    Kenjiro Ono, Mie Hirohata, Masahito Yamada · 2007 · Experimental Neurology
  15. Neurons and Glia Interplay in α-Synucleinopathies
    Panagiota Mavroeidi, Maria Xilouri · 2021 · International Journal of Molecular Sciences
  16. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia
    Wilson Farid Abdo, Bart P.C. van de Warrenburg, Moniek A. M. Munneke, Wieneke J.A. van Geel, Bastiaan R. Bloem, Hannie Kremer, Marcel M. Verbeek · 2006 · Neurology
  17. Changes in the cell population in brain white matter in multiple system atrophy
    Nykjær, Charlotte Havelund, Brudek, Tomasz, Salvesen, Lisette, Pakkenberg, Bente · 2017 · Movement Disorders
  18. Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α -Synucleinopathies
    Kazunari Sekiyama, Shuei Sugama, Masayo Fujita, Akio Sekigawa, Yoshiki Takamatsu, Masaaki Waragai, Takato Takenouchi, Makoto Hashimoto · 2012 · Parkinson s Disease
  19. Viral‐mediated oligodendroglial alpha‐synuclein expression models multiple system atrophy
    Fares Bassil, Paul A. Guerin, Nathalie Dutheil, Qin Li, Matthias Klugmann, Wassilios G. Meissner, Erwan Bézard, Pierre‐Olivier Fernagut · 2017 · Movement Disorders
  20. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions
    Yue Ming Huang, Yun Ju Christine Song, Karen Murphy, Janice L. Holton, Tammaryn Lashley, Tamás Révész, Wei‐Ping Gai, Glenda Margaret Halliday · 2008 · Acta Neuropathologica
  21. Untitled work
    2008 · PubMed
  22. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy
    Yoichi Chiba, Shiro Takei, Noriko Kawamura, Y. Kawaguchi, Kensuke Sasaki, Sanae Hasegawa‐Ishii, Ayako Furukawa, M. Hosokawa, Atsuyoshi Shimada · 2011 · Neuropathology and Applied Neurobiology
  23. Exploring Myelin Dysfunction in Multiple System Atrophy
    Joanna H. Wong, Glenda Margaret Halliday, Woojin Scott Kim · 2014 · Experimental Neurobiology
  24. Neurochemical biomarkers in the differential diagnosis of movement disorders
    Brit Mollenhauer, Claudia Trenkwalder · 2009 · Movement Disorders
  25. Genetic players in multiple system atrophy: unfolding the nature of the beast
    Sylvia Stemberger, Sonja W. Scholz, Andrew Singleton, Gregor Karl Wenning · 2011 · Neurobiology of Aging
  26. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
    Jess-Karan S. Dhillon, Jorge A. Trejo‐Lopez, Cara J. Riffe, Yona Levites, Amanda N. Sacino, David Borchelt, Anthony T. Yachnis, Benoit I. Giasson · 2019 · Acta Neuropathologica Communications
  27. All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration
    Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn, Adrian Israelson · 2021 · Cells
  28. Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease
    D. Papadopoulos, Lisa Ewans, D. Pham-Dinh, J. Knott, R. Reynolds · 2006 · Molecular and Cellular Neuroscience
  29. Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement?
    Cédric Boucherie, Emmanuel Hermans · 2008 · Journal of Neuroscience Research
  30. Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro
    Kenjiro Ono, Mie Hirohata, Masahito Yamada · 2007 · Journal of Neuroscience Research
  31. Glial α‐synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo
    Abby L. Olsen, Mel Β. Feany · 2019 · Glia
  32. Towards translational therapies for multiple system atrophy
    Daniela Kuzdas-Wood, Nadia Stefanova, K. A. Jellinger, Klaus Seppi, Michael G. Schlossmacher, Werner H Poewe, Gregor Karl Wenning · 2014 · Progress in Neurobiology
  33. Management of multiple system atrophy: state of the art
    Carlo Colosimo, Dorina Tiple, Gregor Karl Wenning · 2005 · Journal of Neural Transmission
  34. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss
    Jéssica Grigoletto, Katharina Pukaß, Ayelet Gamliel, Dana Davidi, Rachel Katz‐Brull, Christiane Richter‐Landsberg, Ronit Sharon · 2017 · Acta Neuropathologica Communications
  35. α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
    Francisco Javier Padilla-Godínez, Eunice Ruth Vázquez-García, María Isabel Trujillo-Villagrán, Luis Oskar Soto-Rojas, Marcela Palomero‐Rivero, Omar Hernández-González, Francisco Pérez-Eugenio, Omar Collazo-Navarrete, Óscar Arias-Carrión, Magdalena Guerra‐Crespo · 2025 · Frontiers in Neuroscience
  36. Animal models of multiple system atrophy
    Pierre‐Olivier Fernagut, François Tison · 2011 · Neuroscience
  37. Anti-aggregation Effects of Phenolic Compounds on α-synuclein
    Kenjiro Ono, Mayumi Tsuji, Tritia R. Yamasaki, Giulio Maria Pasinetti · 2020 · Molecules
  38. Age‐related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy
    Fernagut, P.O., Meissner, W.G., Biran, M., Fantin, M., Bassil, F., Franconi, J.M., Tison, F. · 2014 · Synapse
  39. Microtubule Depolymerization Suppresses α-Synuclein Accumulation in a Mouse Model of Multiple System Atrophy
    Kimiko Nakayama, Y. Suzuki, Ikuru Yazawa · 2009 · American Journal Of Pathology
  40. Multiple system atrophy
    Gregor Karl Wenning, Florian Krismer · 2013 · Handbook of clinical neurology
  41. Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy
    Olivier Flabeau, Wassilios G. Meissner, Annaïg Ozier, Patrick Berger, François Tison, Pierre‐Olivier Fernagut · 2014 · Movement Disorders
  42. Oligodendrocytes in neurodegenerative diseases
    Yingjun Liu, Jiawei Zhou · 2013 · Frontiers in Biology
  43. Multiple system atrophy: A prototypical synucleinopathy for disease-modifying therapeutic strategies
    Pierre‐Olivier Fernagut, Benjamin Dehay, Aline Maillard, Erwan Bézard, Paul Perez, Anne Pavy‐Le Traon, Olivier Rascol, Alexandra Foubert‐Samier, François Tison, Wassilios G. Meissner · 2014 · Neurobiology of Disease
  44. Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum
    Tetsutaro Ozawa · 2006 · Acta Neuropathologica
  45. Regulation of α-synuclein expression by liver X receptor ligands in vitro
    Danni Cheng, Woojin Scott Kim, Brett Garner · 2008 · Neuroreport
  46. Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
    Lisa Mészáros, Alana Hoffmann, Jeanette Wihan, Jürgen Winkler · 2020 · International Journal of Molecular Sciences
  47. Cross-examining candidate genes implicated in multiple system atrophy
    Jared S. Katzeff, Katherine Phan, Sivaraman Purushothuman, Glenda Margaret Halliday, Woojin Scott Kim · 2019 · Acta Neuropathologica Communications
  48. FAS-Dependent Cell Death in α-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy
    Christine Lund Kragh, Gwenaëlle Fillon, Amanda M. Gysbers, Hanne Demant Hansen, Manuela Neumann, Christiane Richter‐Landsberg, Christian Haass, Bernard Zalc, Catherine Lubetzki, Wei-Ping Gai et al. · 2013 · PLoS ONE
  49. Models of multiple system atrophy
    He-Jin Lee, Diadem Ricarte, Darlene Mae Ortiz, Seung‐Jae Lee · 2019 · Experimental & Molecular Medicine
  50. Multiple system atrophy variant with severe hippocampal pathology
    Takashi Ando, Yuichi Riku, Akio Akagi, Hiroaki Miyahara, Mitsuaki Hirano, Toshimasa Ikeda, Hiroyuki Yabata, Ryuichi Koizumi, Chisato Oba, Saori Morozumi et al. · 2021 · Brain Pathology
  51. Broad white matter impairment in multiple system atrophy
    Natalia del Campo, Owen Phillips, Fabienne Ory‐Magne, Christine Brefel‐Courbon, Monique Galitzky, Claire Thalamas, Katherine L. Narr, Shantanu H. Joshi, Manpreet K. Singh, Patrice Péran et al. · 2020 · Human Brain Mapping
  52. Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze?
    Vladimir L. Buchman, Natalia N. Ninkina · 2008 · Neurotoxicity Research
  53. Over‐expression of alpha‐synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain
    Heike Siebert, Philipp J. Kahle, Michael L. Kramer, Thomas Isik, Oliver M. Schlüter, Walter Schulz‐Schaeffer, Wolfgang Brück · 2010 · Journal of Neurochemistry
  54. Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies
    Christelle En Lin Chua, Bor Luen Tang · 2011 · Brain Research Reviews
  55. Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
    Somin Lim, Han‐Joon Kim, Dong‐Kyu Kim, Seung‐Jae Lee · 2018 · Progress in Neurobiology
  56. Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy
    Nicole Campese, Alessandra Fanciulli, Nadia Stefanova, Johannes Haybaeck, Stefan Julia Kiechl, Gregor Karl Wenning · 2021 · Journal of Neural Transmission
  57. Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
    Do Hyeon Kwon, Ji Su Hwang, Seok Gi Kim, Yong Eun Jang, Tae Hwan Shin, Gwang Lee · 2022 · International Journal of Molecular Sciences
  58. In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
    Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri · 2020 · Frontiers in Cell and Developmental Biology
  59. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease
    David J. Marmion, Angela Rutkowski, Diptaman Chatterjee, Benjamin M. Hiller, Milton H. Werner, Erwan Bézard, Deniz Kirik, Thomas J. McCown, Steven James Gray, Jeffrey H. Kordower · 2020 · Neurobiology of Disease
  60. An update on the cerebellar subtype of multiple system atrophy
    Ludovico Ciolli, Florian Krismer, Ferdinando Nicoletti, Gregor Karl Wenning · 2014 · Cerebellum & Ataxias
  61. Origin of axonal proteins: Is the axon‐schwann cell unit a functional syncytium?
    Rodrigo López‐Leal, Jaime Álvarez, Felipe A. Court · 2016 · Cytoskeleton
  62. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models
    Guadalupe Vidal-Martínez, Ismael Segura‐Ulate, Barbara Carolyn Yang, Valeria Diaz-Pacheco, Jose A. Barragan, Jocelyn De-Leon Esquivel, Stephanie A. Chaparro, Javier Vargas‐Medrano, Ruth G. Perez · 2019 · Experimental Neurology
  63. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Margaux Teil, Sandra Doveró, Mathieu Bourdenx, Marie-Laure Arotçarena, Sandrine M. J. Camus, Grégory Porras, Marie-Laure Thiolat, Inés Trigo‐Damas, Céline Perier, Cristina M. Estrada et al. · 2021 · Brain
  64. Molecular Chaperones and Associated Cellular Clearance Mechanisms against Toxic Protein Conformers in Parkinson’s Disease
    Marie‐Pierre Hinault, America Farina Henriquez Cuendet, Pierre Goloubinoff · 2011 · Neurodegenerative Diseases
  65. A mouse model of adult-onset multiple system atrophy
    Kunikazu Tanji, Yasuo Miki, Fumiaki Mori, Yoshikazu Nikaido, Hidemi Narita, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayashi · 2019 · Neurobiology of Disease
  66. Late‐stage α‐synuclein accumulation in TNWT‐61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging
    Amit Khairnar, Jana Kučerová, Eva Dražanová, Nikoletta Szabó, Peter Latta, Anas Arab, Birgit Hutter‐Paier, Daniel Havas, Manfred Windisch, Alexandra Šulcová et al. · 2015 · Journal of Neurochemistry
  67. Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy
    Kimiko Nakayama, Y. Suzuki, Ikuru Yazawa · 2011 · Biochemical and Biophysical Research Communications
  68. Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions
    Cara L. Croft, Marshall S. Goodwin, Daniel H. Ryu, Christian B. Lessard, Giancarlo Tejeda, Marc Marrero, Ava R. Vause, Giavanna Paterno, Pedro E. Cruz, Jada M. Lewis et al. · 2021 · Acta Neuropathologica
  69. Overexpression of α‐Synuclein following Methamphetamine
    G Mauceli, Carla Letizia Busceti, Antonio Pellegrini, Paola Soldani, Paola Lenzi, Antonio Paparelli, Francesco Fornai · 2006 · Annals of the New York Academy of Sciences
  70. Intact Olfaction in a Mouse Model of Multiple System Atrophy
    Florian Krismer, Gregor Karl Wenning, Yuntao Li, Werner H Poewe, Nadia Stefanova · 2013 · PLoS ONE
  71. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
    Florent Laferrière, Xin He, Federica Zinghirino, Évelyne Doudnikoff, Emilie Faggiani, Wassilios G. Meissner, Erwan Bézard, Francesca De Giorgi, François Ichas · 2020 · Cells
  72. Transgenic Mouse Models for the Study of Neurodegenerative Diseases
    Alba Marín‐Moreno, Sara Canoyra, Natalia Fernández‐Borges, Juan Carlos Espinosa, Juan María Torres · 2023 · Frontiers in Bioscience-Landmark
  73. Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
    Sonja Mendritzki, Saskia Schmidt, Teresa Sczepan, Xin‐Ran Zhu, Daniel Segelcke, Hermann Lübbert · 2010 · Parkinson s Disease
  74. Regulation of oligodendrocyte differentiation: Insights and approaches for the management of neurodegenerative disease
    Abdullah Mohammad Tauheed, Joseph Olusegun Ayo, Mohammed Umaru Kawu · 2016 · Pathophysiology
  75. “Multiple system atrophy: experimental models and reality”.
    C. Overk, E. Rockenstein, Elvira Valera, N. Stefanova, G. Wenning, E. Masliah · 2017 · Acta Neuropathologica
  76. Parkinson’s disease: what the model systems have taught us so far
    Swagata Ghatak, Dorit Trudler, Nima Dolatabadi, Rajesh Ambasudhan · 2018 · Journal of Genetics
  77. MSA: From basic mechanisms to experimental therapeutics
    Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Parkinsonism & Related Disorders
  78. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium.
    Allan Kupferman, Howard M. Leibowitz · 1975 · PubMed
  79. Animal modeling an oligodendrogliopathy – multiple system atrophy
    Bleasel, Jonathan M., Halliday, Glenda M., Kim, Woojin Scott · 2016 · Acta Neuropathologica Communications
  80. ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
    Mai Horiuchi, Seiji Watanabe, Okiru Komine, Eiki Takahashi, Kumi Kaneko, S. Itohara, Mayuko Shimada, T. Ogi, Koji Yamanaka · 2024 · Acta Neuropathologica Communications
  81. A New Rise of Non-Human Primate Models of Synucleinopathies
    Margaux Teil, Marie-Laure Arotçarena, Benjamin Dehay · 2021 · Biomedicines
  82. The genetic basis of multiple system atrophy
    Fan Shuen Tseng, Joel Qi Xuan Foo, Aaron Shengting Mai, Eng‐King Tan · 2023 · Journal of Translational Medicine
  83. The role of α-synuclein in neurodegeneration — An update
    K. A. Jellinger · 2012 · Translational Neuroscience
  84. Towards New Therapies for Parkinson's Disease
    David Isaac Finkelstein · 2011 · InTech eBooks
  85. Models of Multiple System Atrophy
    Lisa Fellner, Gregor Karl Wenning, Nadia Stefanova · 2013 · Current topics in behavioral neurosciences
  86. Quantitative susceptibility mapping depicts severe myelin deficit and iron deposition in a transgenic model of multiple system atrophy
    Vera Lambrecht, Jannis Hanspach, Alana Hoffmann, Lisa Seyler, Angelika Mennecke, Sina Straub, Franz Marxreiter, Tobias Bäuerle, Frederik Bernd Laun, Jürgen Winkler · 2020 · Experimental Neurology
  87. Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
    Pons-Espinal, Meritxell, Blasco-Agell, Lucas, Consiglio, Antonella · 2021 · Cellular and Molecular Life Sciences
  88. α-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy
    Hiroshi Ito, Kimiko Nakayama, Cheng Hua Jin, Y. Suzuki, Ikuru Yazawa · 2012 · Biochemical and Biophysical Research Communications
  89. Characterization of spheroids in hereditary diffuse leukoencephalopathy with axonal spheroids
    Cheng Hua Jin, Yukihiko Washimi, Kunihiro Yoshida, Yoshio Hashizume, Ikuru Yazawa · 2015 · Journal of the Neurological Sciences
  90. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
    Francesco De Nuccio, Marianna Kashyrina, Francesca Chiara Serinelli, Florent Laferrière, Dario Domenico Lofrumento, Francesca De Giorgi, François Ichas · 2023 · Biomolecules
  91. Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease
    Koichi Wakabayashi, Yasuo Miki, Kunikazu Tanji, Fumiaki Mori · 2022 · The Cerebellum
  92. Oxidative Modulation of K + Channels in the Central Nervous System in Neurodegenerative Diseases and Aging
    Chris Peers, John P. Boyle · 2014 · Antioxidants and Redox Signaling
  93. Mechanisms and models of α-synuclein-related neurodegeneration
    Wolfdieter Springer, Philipp J. Kahle · 2006 · Current Neurology and Neuroscience Reports
  94. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy
    Tomoya Kon, Shelley L. Forrest, Seojin Lee, Jun Li, Helen Chasiotis, Nasna Nassir, Mohammed J. Uddin, Anthony Edward Lang, Gábor Géza Kovács · 2024 · Neurobiology of Disease
  95. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates
    Hiroo Yamaguchi, Yuji Nishimura, Dai Matsuse, Hiroaki Sekiya, Katsuhisa Masaki, Tatsunori Tanaka, Toru Saiga, Masaya Harada, Yuu‐ichi Kira, Dennis W. Dickson et al. · 2024 · Brain Behavior and Immunity
  96. Cystatin C Triggers Neuronal Degeneration in a Model of Multiple System Atrophy
    Y. Suzuki, Cheng Hua Jin, Ikuru Yazawa · 2014 · American Journal Of Pathology
  97. In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells
    Elena Abati, Alessio Di Fonzo, Stefania Paola Corti · 2018 · Journal of Cellular and Molecular Medicine
  98. Protein Disulfide Isomerase Immunopositive Glial Cytoplasmic Inclusions in Patients With Multiple System Atrophy
    Yasuyuki Honjo, Hidefumi Ito, Tomohisa Horibe, Ryōsuke Takahashi, Koji Kawakami · 2011 · International Journal of Neuroscience
  99. A historical review of multiple system atrophy with a critical appraisal of cellular and animal models
    David J. Marmion, Wouter Peelaerts, Jeffrey H. Kordower · 2021 · Journal of Neural Transmission
  100. Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy
    Martin Köllensperger, Nadia Stefanova, Markus Reindl, Werner H Poewe, Gregor Karl Wenning · 2006 · Movement Disorders